Get Level 2

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Vernalis PLC Share Price
  4. Vernalis PLC Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksVernalis PLC Regulatory News (VER)

Vernalis PLC Information
  • There is currently no data for VER

Director/PDMR Shareholding

29 Dec 2008 10:00

RNS Number : 7651K
Vernalis PLC
29 December 2008
 



Vernalis PLC 

29 December 2008 

 

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS 

 

 

VERNALIS PLC 

 

 

WINNERSH, U.K 29th December 2008 Vernalis plc (LSE: VER) announces that in accordance with DTR 3.1.2R and  following a resolution by the Board of Vernalis plc passed in accordance with share scheme arrangements approved by shareholders, the following options over new ordinary shares of 5p each in the Company were today granted to the new Chief Executive Officer: 

 

 

Executive   No of shares Exercise Price % of Issued Share

Director under option Capital 

Ian Garland 9,750,000 5p 2.68% 

 

The options are exercisable between three and ten years following grant provided that the performance conditions of the option scheme are met.

 

 

Vernalis plc 

+44 (0) 118 977 3133 

Dr Peter Fellner

Executive Chairman 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPUGUGPUPRGUC
12345678910
Date   Source Headline
27th Sep 20137:00 amRNSAppointment of Nominated Advisor and Broker
26th Sep 201311:52 amRNSHolding(s) in Company
12th Sep 20135:41 pmRNSHolding(s) in Company
29th Jul 20134:00 pmRNSHolding(s) in Company
29th Jul 20137:00 amRNSInterim results for six months ended 30 June 2013
26th Jul 20135:45 pmRNSHolding(s) in Company
26th Jul 20135:10 pmRNSHolding(s) in Company
26th Jul 20134:48 pmRNSHolding(s) in Company
12th Jul 20137:00 amRNSVernalis Initiates Phase Ib/II POC Study of V81444
11th Jul 20137:00 amRNSNotice of Results for 6 months ended 30 June 2013
8th Jul 20133:17 pmRNSHolding(s) in Company
13th Jun 20137:00 amRNSFrovatriptan data to be presented at IHC
22nd May 201311:43 amRNSResult of AGM
29th Apr 20135:10 pmRNSHolding(s) in Company
26th Apr 201311:29 amRNSTransaction of Directors
19th Apr 201312:00 pmRNSTransaction by Directors
17th Apr 20139:22 amRNSNotice of Annual Report and AGM
16th Apr 201312:24 pmRNSTransactions of Directors/Applicable Employees
10th Apr 20137:00 amRNSAnnouncement of Results for year ended 31/12/12
21st Mar 20137:00 amRNSNotice of Results
19th Mar 20135:34 pmRNSHolding(s) in Company
6th Mar 20137:15 amRNSVernalis and Servier Extend Oncology Collaboration
6th Mar 20137:00 amRNSFirst Product in Cough Cold Pipeline Achieves POC
4th Mar 20137:00 amRNSVernalis received a further $2.5m from Genentech
8th Feb 20134:10 pmRNSHolding(s) in Company
4th Feb 20137:00 amRNSVernalis receives $1.5 m milestone from Genentech
7th Jan 20137:00 amRNSVernalis and Servier Achieve Research Milestone
2nd Jan 20138:36 amRNSVernalis and Lundbeck Achieve Third Milestone
12th Dec 20127:00 amRNSPositive Results Achieved in RO Study of V81444
20th Sep 20127:00 amRNSVernalis & Servier Achieve Research Milestone
4th Sep 20127:00 amRNSDirector/PDMR Shareholding
22nd Aug 20127:00 amRNSVernalis Initiates V81444 Receptor Occupancy Study
13th Aug 20127:00 amRNSVernalis to present at 14th World Congress on Pain
10th Aug 20122:56 pmRNSHolding(s) in Company
1st Aug 20127:00 amRNSInterim Results for six months ended 30 June 2012
10th Jul 201210:00 amRNSNotice of Results
1st Jun 201210:00 amRNSAUY922 Abstracts Accepted for Presentation at ASCO
30th May 20127:46 amRNSDirector/Applicable Employee Shareholding
22nd May 201212:50 pmRNSResult of AGM
2nd May 20127:00 amRNSSuccessful Outcome for V81444 in Phase I Study
27th Apr 20128:00 amRNSCancellation Vernalis Plc
27th Apr 20127:00 amRNSADMISSION OF SHARES TO AIM
26th Apr 20125:38 pmRNSChange of Registered Office
25th Apr 20127:00 amRNSVernalis and Servier Achieve Research Milestone
18th Apr 20125:05 pmRNSNotice of Annual Report and Annual General Meeting
3rd Apr 20127:00 amRNSAnnouncement of Results year ended 31 Dec 2011
27th Mar 20127:00 amRNSSchedule 1 - Vernalis plc
27th Mar 20127:00 amRNSCancellation of Listing/Proposed Admission to AIM
14th Mar 20127:00 amRNSNotice of Results
9th Mar 20125:07 pmRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
BRBY
Burberry
LSE
-2.31%
32QX
Telecom Egypt
LSE
0.00%
LIO
Liontrust Asset Management
LSE
-3.81%
SAGA
Saga
LSE
-5.86%
AAL
Anglo American
LSE
-3.10%
Trending
GGP
Greatland Resources
LSE
-5.79%
AVCT
Avacta Group
LSE
-2.13%
PREM
Premier African Minerals
LSE
3.03%
QED
Quadrise
LSE
-27.01%
QBT
Quantum Block
LSE
0.00%